아이언우드 파마슈티컬스, Inc.
US ˙ NasdaqGS ˙ US46333X1081

SecurityIRWD / Ironwood Pharmaceuticals, Inc.
InstitutionRoyce Value Trust Inc
Latest Disclosed Ownership709,188 shares
Latest Disclosed Value $ 508,629
Royce Value Trust Inc ownership in IRWD / Ironwood Pharmaceuticals, Inc.

On August 15, 2025 - Royce Value Trust Inc filed a NPORT-P form disclosing ownership of 709,188 shares of Ironwood Pharmaceuticals, Inc. (US:IRWD) valued at $508,630 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 19, 2025 disclosing 709,188 shares of Ironwood Pharmaceuticals, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $2,347,412 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-15 2025-06-30 NP Ironwood Pharmaceuticals EC US46333X1081 709,188 0 0.00 509 -51.25 0.0254
2025-05-19 2025-03-31 NP Ironwood Pharmaceuticals EC US46333X1081 709,188 0 0.00 1,043 -66.83 0.0566
2025-02-21 2024-12-31 NP Ironwood Pharmaceuticals EC US46333X1081 709,188 58,946 9.07 3,142 17.29 0.1572
2024-11-19 2024-09-30 NP Ironwood Pharmaceuticals EC US46333X1081 650,242 64,353 10.98 2,679 -29.88 0.1326
2024-08-12 2024-06-30 NP Ironwood Pharmaceuticals EC US46333X1081 585,889 7,577 1.31 3,820 -24.18 0.2002
2024-05-28 2024-03-31 NP Ironwood Pharmaceuticals EC US46333X1081 578,312 289,675 100.36 5,037 52.54 0.2575
2024-02-20 2023-12-31 NP Ironwood Pharmaceuticals EC US46333X1081 288,637 14,013 5.10 3,302 24.89 0.1771
2023-11-22 2023-09-30 NP Ironwood Pharmaceuticals EC US46333X1081 274,624 1,455 0.53 2,645 -9.02 0.1590
2023-08-09 2023-06-30 NP Ironwood Pharmaceuticals EC US46333X1081 273,169 -57,240 -17.32 2,907 -16.37 0.1658
2023-05-19 2023-03-31 NP Ironwood Pharmaceuticals EC US46333X1081 330,409 126,635 62.14 3,476 37.68 0.2060
2023-02-21 2022-12-31 NP Ironwood Pharmaceuticals EC US46333X1081 203,774 96,224 89.47 2,525 126.57 0.1573
2022-11-17 2022-09-30 NP Ironwood Pharmaceuticals EC US46333X1081 107,550 52,643 95.88 1,114 75.99 0.0755
2022-08-16 2022-06-30 NP Ironwood Pharmaceuticals EC US46333X1081 54,907 19,600 55.51 633 42.57 0.0400
2022-05-16 2022-03-31 NP Ironwood Pharmaceuticals EC US46333X1081 35,307 35,307 444 0.0232
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.